Clinical characteristics, respiratory management, and determinants of oxygenation in COVID-19 ARDS: A prospective cohort study.


Journal

Journal of critical care
ISSN: 1557-8615
Titre abrégé: J Crit Care
Pays: United States
ID NLM: 8610642

Informations de publication

Date de publication:
10 2022
Historique:
received: 03 02 2022
revised: 19 02 2022
accepted: 22 02 2022
pubmed: 30 3 2022
medline: 3 9 2022
entrez: 29 3 2022
Statut: ppublish

Résumé

To identify determinants of oxygenation over time in patients with COVID-19 acute respiratory distress syndrome (ARDS); and to analyze their characteristics according to Berlin definition categories. Prospective cohort study including consecutive mechanically ventilated patients admitted between 3/20/2020-10/31/2020 with ARDS. Epidemiological and clinical data on admission; outcomes; ventilation, respiratory mechanics and oxygenation variables were registered on days 1, 3 and 7 for the entire population and for ARDS categories. 1525 patients aged 61 ± 13, 69% male, met ARDS criteria; most frequent comorbidities were obesity, hypertension, diabetes and respiratory disease. On admission, 331(21%), 849(56%) and 345(23%) patients had mild, moderate and severe ARDS; all received lung-protective ventilation (mean tidal volumes between 6.3 and 6.7 mL/kg PBW) and intermediate PEEP levels (10-11 cmH Hypoxemia in patients with COVID-19-related ARDS is associated with comorbidities, deadspace and activated coagulation markers, and disease severity-reflected by the PEEP level required.

Identifiants

pubmed: 35349967
pii: S0883-9441(22)00049-1
doi: 10.1016/j.jcrc.2022.154021
pmc: PMC8957289
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

154021

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no conflict of interest.

Références

Int J Obes (Lond). 2021 Sep;45(9):2028-2037
pubmed: 34112941
Crit Care. 2020 Apr 16;24(1):154
pubmed: 32299472
Am J Respir Crit Care Med. 2019 Feb 1;199(3):333-341
pubmed: 30211618
Lancet Respir Med. 2017 Aug;5(8):627-638
pubmed: 28624388
Thorax. 2008 Oct;63(10):925-31
pubmed: 18820119
Sci Rep. 2021 Feb 12;11(1):3735
pubmed: 33580190
Intensive Care Med. 2020 Nov;46(11):2092-2093
pubmed: 32737523
Front Med (Lausanne). 2021 Jun 16;8:668808
pubmed: 34222281
Crit Care Med. 2022 Apr 1;50(4):633-643
pubmed: 34582426
Br J Anaesth. 2020 Dec;125(6):e480-e483
pubmed: 32962855
Am J Pathol. 1983 Jul;112(1):112-26
pubmed: 6859225
JAMA. 2020 Dec 22;324(24):2548-2549
pubmed: 33226423
Crit Care. 2020 Aug 28;24(1):529
pubmed: 32859264
Intensive Care Med. 2020 Nov;46(11):2086-2088
pubmed: 33000290
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Am J Respir Crit Care Med. 2020 Jul 1;202(1):1-4
pubmed: 32402207
JAMA. 2016 Feb 23;315(8):788-800
pubmed: 26903337
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
Am J Respir Crit Care Med. 2020 Dec 15;202(12):1713-1717
pubmed: 33075235
Lancet Respir Med. 2020 Dec;8(12):1201-1208
pubmed: 32861276
N Engl J Med. 2002 Apr 25;346(17):1281-6
pubmed: 11973365
Intensive Care Med. 2020 Dec;46(12):2200-2211
pubmed: 32728965
Intensive Care Med. 2003 Nov;29(11):1936-42
pubmed: 12955187
Am J Respir Crit Care Med. 2020 May 15;201(10):1297-1299
pubmed: 32203672
BMC Public Health. 2021 Aug 4;21(1):1505
pubmed: 34348687
Intensive Care Med. 2020 Jun;46(6):1099-1102
pubmed: 32291463
Am J Respir Crit Care Med. 2010 Jul 1;182(1):41-8
pubmed: 20203241
Intensive Care Med. 2021 Jan;47(1):60-73
pubmed: 33211135
Ann Intern Med. 2020 Aug 18;173(4):268-277
pubmed: 32374815
JAMA. 2017 Oct 10;318(14):1335-1345
pubmed: 28973363
Intensive Care Med. 2020 Jun;46(6):1105-1108
pubmed: 32347323
Acta Diabetol. 2020 Jun;57(6):759-764
pubmed: 32249357
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Eur Respir J. 2020 May 14;55(5):
pubmed: 32269089
Am J Respir Crit Care Med. 2017 May 1;195(9):1253-1263
pubmed: 28459336
Crit Care. 2021 Apr 6;25(1):128
pubmed: 33823862
Lancet Respir Med. 2014 May;2(5):380-6
pubmed: 24740011
Lancet Respir Med. 2021 Sep;9(9):989-998
pubmed: 34224674
Lancet Respir Med. 2021 Apr;9(4):407-418
pubmed: 33460571

Auteurs

Elisa Estenssoro (E)

Hospital Interzonal de Agudos General San Martín, Buenos Aires, Argentina. Electronic address: estenssoro.elisa@gmail.com.

Cecilia I Loudet (CI)

Hospital Interzonal de Agudos General San Martín, Buenos Aires, Argentina.

Arnaldo Dubin (A)

Sanatorio Otamendi, Buenos Aires, Argentina.

Vanina S Kanoore Edul (VS)

Hospital Juan A Fernández, Buenos Aires, Argentina.

Gustavo Plotnikow (G)

Sanatorio Anchorena, Buenos Aires, Argentina.

Macarena Andrian (M)

Hospital Provincial Dr Castro Rendón, Neuquén, Argentina.

Ignacio Romero (I)

Sanatorio Güemes, Buenos Aires, Argentina.

Judith Sagardía (J)

Hospital A Posadas, Buenos Aires, Argentina.

Marco Bezzi (M)

Hospital Santojanni, Buenos Aires, Argentina.

Verónica Mandich (V)

Hospital Santojanni, Buenos Aires, Argentina.

Carla Groer (C)

Hospital Juan A Fernández, Buenos Aires, Argentina.

Sebastián Torres (S)

Sanatorio Anchorena San Martín, Buenos Aires, Argentina.

Cristina Orlandi (C)

Hospital Francisco López Lima, Río Negro, Argentina.

Paolo N Rubatto Birri (PN)

Sanatorio Otamendi, Buenos Aires, Argentina.

María F Valenti (MF)

Sanatorio de Los Arcos, Buenos Aires, Argentina.

Eleonora Cunto (E)

Hospital Dr. F J Muñiz, Buenos Aires, Argentina.

María G Sáenz (MG)

Hospital Interzonal de Agudos General San Martín, Buenos Aires, Argentina.

Norberto Tiribelli (N)

Complejo Médico de la Policía Federal Argentina Churruca Visca, Buenos Aires, Argentina.

Vanina Aphalo (V)

Sanatorio Anchorena, Buenos Aires, Argentina.

Lisandro Bettini (L)

Hospital Provincial del Centenario, Santa Fe, Argentina.

Fernando G Ríos (FG)

Sanatorio Las Lomas, Buenos Aires, Argentina.

Rosa Reina (R)

Sociedad Argentina de Terapia Intensiva, Buenos Aires, Argentina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH